American Journal of Nephrology
Clinical Study
Localization of Autonomic Nervous System Dysfunction in Dialysis PatientsNakashima Y. · Fouad F.M. · Nakamoto S. · Textor S.C. · Bravo E.L. · Tarazi R.C.Research Institute of The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Keywords: NeuropathyReflexesUremiaDialysis |
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: November 07, 1986
Accepted: March 27, 1987
Published online: October 24, 2008
Issue release date: 1987
Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 0
ISSN: 0250-8095 (Print)
eISSN: 1421-9670 (Online)
For additional information: https://www.karger.com/AJN
Abstract
Autonomic nervous system dysfunction has been described frequently in uremic patients. The purpose of this study is to determine the localization of this abnormality and to study the possible relationship between autonomic dysfunction and the occurrence of dialysis hypotension. Sixteen consecutive patients participated in the study, 5 of whom had a history of dialysis-induced hypotension. These 5 patients were compared to the other 11 as regards the cardiovascular response to isoproterenol infusion, tilt test and arteriovenous (AV) fistula occlusion. None of the responses to the above mentioned stimuli was significantly different between the 2 groups. In the whole study population, an index of parasympathetic control of heart rate (variation of heart period, VHP) was reduced (31 ± 5 vs. 59 ± 9 ms in age-matched controls; p < 0.025). Heart rate and diastolic blood pressure response to isoproterenol infusion was normal (+23 ± 2 beats/min and -9 ± 3 mm Hg; p < 0.005 for both), indicating normal response of effector organs to beta-adrenergic agonist stimulation. Similarly, plasma norepinephrine increased significantly (+294 ± 51 pg/ml; p = NS from normal laboratory values) in response to head-up tilt, and heart rate increased simultaneously in all but 5 patients. Blood pressure response was within normal after 10 min of head-up tilt at 60° in all but 3 patients; only 1 of these 3 patients was in the group of dialysis hypotension. However, during AV fistula occlusion, heart rate did not change markedly, despite the significant increase in systolic blood pressure, suggesting an altered sensitivity of baroreceptor reflex arc. Since VHP was abnormal, the possibility exists that the blunted response of heart rate during AV fistula occlusion was due to impaired efferent rather than afferent vagal pathway of the baroreflex arc. The present study indicates that autonomic nervous system dysfunction in hemodialysis patients involves cardiac efferent parasympathetic pathway whereas adrenergic responses are within normal. These findings could not explain the occurrence of dialysis hypotension in this population. The latter is probably due to hemodynamic factors.
© 1987 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Received: November 07, 1986
Accepted: March 27, 1987
Published online: October 24, 2008
Issue release date: 1987
Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 0
ISSN: 0250-8095 (Print)
eISSN: 1421-9670 (Online)
For additional information: https://www.karger.com/AJN
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission